Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
SEPTEMBER 2022LIFE SCIENCES REVIEW5CIO INSIGHTSCXO INSIGHTSCurtis Bernard,Head of Regulatory Strategy, SanofiWhy Life Sciences Industry Must Prioritize Business Validation20Bobby Prill,Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. Yong Yue,Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.Challenges and Opportunities for AI in Drug Discovery2224Shola Oyewole,CIO,United Therapeutics Corporation [NASDAQ: UTHR]Advanced Therapies for Patients Suffering from PAH26Emily Madigan, Director Regulatory affairs,Merck groupEU Regulatory Reforms to Impact the Global Life Science Industry28Stefan Fischer, Senior Director Compliance, NovartisEurope to Transform AI Regulatory Landscape18How Regulatory has Become Strategically Important to Food and Feed CompaniesCaroline Herody, Head of Global Regulatory Affairs,Chr. HansenREGULATORYSERVICES COMPANIES IN EUROPE - 2022TOP 10FreyrRajiv Rangan,Co-Founder & Co-CEO21AtessiaGéraldine Baudot-Visser,CEO19FEATURED companies
< Page 4 | Page 6 >